Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etonogestrel PK with NNRTI-based ART in HIV-infected Women
NCT02082652Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2014
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of etonogestrel in contraception (3 arms), sponsored by University of Pittsburgh. Primary endpoint: Etonogestrel plasma concentrations at 6 months. Started Oct 2014; status: completed.
02
Drugs
etonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02082652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02082652.